phylloquinone/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases all-site cancer incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Cancer incidence was lower in the vitamin K group than in the placebo group (three versus 12, p = 0.02; HR = 0.25, 95% CI 0.07 to 0.89).”
Quoted verbatim from Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.. - Study
- RCT
- Dose
- 5 mg vitamin K1 daily
- Population
- Postmenopausal women with osteopenia, vitamin D replete, receiving calcium and vitamin D in both arms; follow-up up to 4 years
Effect 0.25 hazard ratio, 95% CI 0.07 to 0.89
Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.2008PMID:18922041Permalink
Keep reading
- Everything the graph holds on phylloquinone
- Every compound studied against All-site cancer incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5MHSPTH6TEKMTCET13VHHHY